Wellspring Capital Management has acquired National Seating & Mobility (NSM), a provider of complex rehab technology (CRT) solutions for individuals with permanent or long-term mobility loss, from Ridgemont Equity Partners. Financial terms of the transaction have not been disclosed. Headquartered in Nashville, Tennessee, NSM provides CRT solutions that assist with loss of mobility due to trauma, physical abnormality, structural defect or disease. NSM designs and assembles customised wheelchairs and adaptive seating systems that play an essential role in improving the lives of patients by enhancing their functionality, maximising their independence and providing an ability to participate in the community. Operating

An affiliate of UK Sun European Partners, the European adviser to Sun Capital Partners, has acquired a majority stake in Paragon Print and Packaging, a provider of packaging and outsourced services to the private label fresh and chilled food market. The value of the transaction has not been disclosed. Established in 1994, the Paragon Print and Packaging Group is comprised of four divisions supplying printed labels, sleeves, cartons, lined board, film and artwork. The group operates from ten UK manufacturing facilities totalling in excess of 650,000 sq ft, employs approximately 1,200 staff and has a turnover exceeding GBP170m. The group

BaltCap has invested in Coffee Inn, the largest branded coffee shop chain in the Baltics. Coffee Inn intends to invest up to EUR2m of debt and equity capital over the coming two years to finance the future growth of the business in Lithuania and other countries.   Coffee Inn was established in Vilnius in 2007 by a group of Lithuanian entrepreneurs. Today, the company operates 28 branded coffee shops and expects to have sales over EUR3m in 2012. Coffee Inn shops are located in Vilnius, Kaunas, Klaipeda, Palanga, Siauliai and Riga, Latvia.   Vygantas Maksele, the chief executive of Coffee

Albéa, an affiliate of Sun European Partners, has completed the acquisition of Rexam Personal Care, Cosmetic division, a producer of dispensing systems and make up packaging for the cosmetic and personal care markets.  The division operates 11 plants in Europe, the Americas and Asia. This follows Rexam’s announcement on 3 July 2012 on the proposed sale of its personal care business.   With this new acquisition, Albéa expands its packaging solutions to dispensing systems and reinforces its offer in tubes, cosmetic rigid packaging, and beauty solutions. It also strengthens Albéa’s position in emerging markets to develop its wide product portfolio

Water Street Healthcare Partners, a private equity firm focused exclusively on the healthcare industry, has sold Precision Dynamics Corporation (PDC) to Brady Corporation in a cash transaction for USD300m, subject to customary working capital and post-close adjustments. Water Street divested PDC after spending five years building the company into a global leader in patient safety identification (ID) through a combination of strategic acquisitions and organic initiatives. Headquartered in Valencia, California, PDC designs and manufactures products used by hospitals across the US to reduce medical errors, and integrate and share patient data. Water Street partnered with PDC’s founders and management team

Private equity firm GTCR has completed the acquisition of Correctional Healthcare Companies (CHC), an outsourced healthcare provider to correctional facilities. GTCR is partnering with CHC chief executive Doug Goetz, chief operating officer Don Houston and managed care industry executive Dale Wolf to grow and expand the business. This investment results from GTCR’s proactive efforts with Wolf and Jessamine Healthcare, a management startup with Wolf, targeted at a range of healthcare cost containment and payor businesses. Wolf, former chief executive of Coventry Health Care, has joined CHC as executive chairman as part of the transaction. CHC provides inmate healthcare services to

JHP Pharmaceuticals, a pharmaceutical company that acquires, develops, manufactures and sells sterile injectable products, has been acquired by an affiliate of private equity firm Warburg Pincus. The company was acquired from JHP Holdings, an entity majority-owned by Morgan Stanley Principal Investments, for USD195m on a debt-free, cash-free basis.  JHP’s current management team will continue to hold an interest in the company. Since its founding in 2007, JHP has developed into a leading specialty pharmaceutical company focused on the USD30bn US sterile injectable drug market. JHP’s market presence, high-quality sterile manufacturing facility, and experienced management team, coupled with growth capital and

Independent financial advisory and investment banking firm Duff & Phelps is to be acquired by a consortium comprising controlled affiliates of or funds managed by The Carlyle Group, Stone Point Capital, Pictet & Cie and Edmond de Rothschild Group for USD15.55 per share in cash in a transaction valued at approximately USD665.5m. The offer represents a 19.2 per cent premium to the closing price of Duff & Phelps shares on 28 December 2012, and 27.3 per cent over the company’s volume weighted average share price during the 30 days ended 28 December 2012. The transaction is expected to close in